Absci Corporation (ABSI) Stock Ticker
ABSI right now
Market factors today
Unlock the full ABSI picture
About Absci Corporation
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.
ABSI stock facts
| Ticker symbol | ABSI |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.6B |
| CEO | Sean McClain |
| Employees | 140 |
| Headquarters | Vancouver, WA, US |
| IPO date | 2021-07-22 |
| Website | www.absci.com |
What you can see for ABSI on Tickr
Live ABSI price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ABSI report.
Rankings
FAQ
What is the ticker symbol for Absci Corporation?
The ticker symbol for Absci Corporation is ABSI, listed on the NASDAQ Global Select.
What is ABSI?
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This…